Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Unknown 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 20Leukemia, Myeloid, Acute 20Myelodysplastic Syndromes 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Leukemia 16Hodgkin Disease 15Multiple Myeloma 14Lymphoma 14Lymphoma, Mantle-Cell 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Follicular 12Lymphoma, B-Cell, Marginal Zone 11Burkitt Lymphoma 10Primary Myelofibrosis 9Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myelomonocytic, Chronic 9Neoplasms, Plasma Cell 8Leukemia, Myelomonocytic, Juvenile 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Congenital Abnormalities 8Anemia, Refractory, with Excess of Blasts 8Sezary Syndrome 7Mycosis Fungoides 7Blast Crisis 7Myeloproliferative Disorders 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Large-Cell, Anaplastic 6Leukemia, Myeloid, Chronic-Phase 6

Interventions

Bortezomib 5Rituximab 4tanespimycin 3fludarabine phosphate 3Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Lenalidomide 3Dasatinib 3Vorinostat 2Radiotherapy 2Melphalan 2Etoposide 2Antilymphocyte Serum 2plerixafor 1obatoclax 1nelarabine 1etoposide phosphate 1belinostat 1amuvatinib 1alvocidib 1Whole-Body Irradiation 1Vincristine 1Tetradecanoylphorbol Acetate 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiation 1Oxycodone 1Oxaliplatin 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Immunoblastic Lymphadenopathy × Mycophenolic Acid × Clear all
NCT00827099 2012-03-23

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Northside Hospital, Inc.

Phase 2 Terminated
5 enrolled 5 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡